Immuron
NASDAQ: IMRN2 known investors
Find your way into Immuron
Sign up to see every warm intro you have to Immuron
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Immuron team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Immuron is an Australian biopharmaceutical company developing and commercialising targeted polyclonal antibodies aimed at addressing unmet medical needs. Its products, based on a patented technology platform, are formulated to reduce diarrhoea, support gastrointestinal and digestive health, and promote immune defence.
Founders & leadership
Investors · 2
Frequently asked questions
- What does Immuron do?
- Immuron is an Australian biopharmaceutical company developing and commercialising targeted polyclonal antibodies aimed at addressing unmet medical needs. Its products, based on a patented technology platform, are formulated to reduce diarrhoea, support gastrointestinal and digestive health, and promote immune defence.
- Who are Immuron's investors?
- Immuron's investors include Silver Lake Partners, venBio Partners.